Sie sind auf Seite 1von 3

Brad S.

San Francisco, California 94123
Seattle, Washington 98056
(415) 571-4724

Marketing, Sales and General Management Executive
Multi-award winning executive with record of consistently delivering results in diverse leadership roles.

Over 20 years experience with industry-leading and start-up biotechnology, pharmaceutical, information
technology and healthcare companies, including oncology and genomics.
Passion for translating innovative solutions into behavior-changing strategies and communications.

Demonstrated skill defining and linking actionable key insights to strategic and tactical plans
that most efficiently grow launch and marketed brands

Launch marketing leader for 5 major brands, each of which beat industry analyst forecasts.
On average, revenues exceeded forecast by 34%, among 5 brands.

Customer-centric focus based on rare blend of strategic and execution-focused roles in
marketing, field sales management and market research

Repeatedly placed in leadership roles with high level of corporate priority and/or commercial

U.S. and Global Marketing Sales Leadership Market Research Information Technology
Market Assessment Strategic and Tactical Planning Product Launch (5) New Product Planning
Positioning Segmentation Multichannel Integration Digital Marketing Patient Marketing
Life Cycle Management Payer Planning Access and Reimbursement Clinical Acumen

Therapeutic Areas: Oncology, hematology, neuroscience, immunology, metabolism, diabetes,
cardiovascular, autoimmune and movement disorders.


Renaissance Systems, Inc., San Francisco, California | Seattle, Washington

Senior Director of Marketing and Commercial Operations 2/2013 Present

Returned growth trajectory by leading entry into healthcare sector
Led expansion into biotechnology / healthcare sector for information technology solutions provider.
Successfully led market needs assessment, solution identification, strategic and tactical planning for newly
formed business unit. Recruited to lead team based on prior experience in healthcare and payer
Key Achievements:
Increased company sales 19% (Q1+2 2014 vs. Q1+2 2013) by executing strategy for IT solution that
enhances biopharma industry value proposition to payers
Led solution development teams and provided commercial and healthcare guidance
Coordinate ongoing product development, distribution, account management, business development
and customer support teams
Forecast, develop, and administer departmental budget

Medivation, Inc., San Francisco, California

Director of Marketing Oncology and Urology 1/2012 2/2013

Directed marketing for launch of flagship brand
Led marketing team in pre-launch commercialization, launch readiness, product launch and brand
management for Medivations flagship brand, Xtandi under aggressive launch timelines (8 months).
Focused team on delivering well-differentiated strategic and tactical plans to unseat entrenched competitor
with high satisfaction ratings among target oncologists (85% extremely/highly satisfied).
Key Achievements:
Captured 17% market share in less than 90 days with a well-differentiated competitive strategy, position,
message and tactical plan
Oversaw and/or created integrated strategic and tactical plans for HCP, direct-to-HCP, patient, digital,
KOLs, speaker's bureau, advocacy, PR and managed market functions

Amgen, Inc., Thousand Oaks, California 2004 2012

Director of Marketing Oncology and Urology 3/2011 1/2012

Led expansion into urology market
Brand management responsibilities for Xgeva during growth and expansion phase into urology market.
Engineered strategic and tactical plan for future indication.
Key Achievements:
Monitored, measured and optimized marketing mix across HCP, patient and payer channels.
Led team of 5 senior managers in development of 3/1 strategic brand plan, forecast and budget.

Regional Sales Management Hematology, Oncology and Urology 10/2007 3/2011

Led turn-around in team performance
Identified by executive management to lead team in turn-around efforts based on history of successful
management of in-line and matrix teams in challenging environments. Grew revenue in excess of national
average across clinic (2.9x), hospital (4.2x) and government (1.6x) settings.
Key Achievements:
Transformed team performance from bottom 5% for 3 prior years to #2 in the nation. Consistent
improvement year-over-year; ranked #16 in 2008, #12 in 2009 and #2 in 2010 (out of 40 teams).
Grew revenue over 3 year period at 3.5 times the national average representing a 24% CAGR.
Increased annual revenue from $162M to $308M (2007 2010).
Honored with Team Excellence award, named Coach of the Year, and awarded Chairmans Circle
for exemplary team leadership

Director of Global Marketing Hematology, Oncology and Metabolism 5/2004 11/2007

Led 7-asset portfolio plus global product launch
Oversaw 7 product strategy teams governing all aspects of clinical research, operations, manufacturing and
global marketing. Took over global launch preparation role for Nplate

, an injectable which would become

the first peptibody approved by the FDA. A successful launch was dependent on challenging conventional
wisdom of the disease state and differentiation from a competitor with oral administration among HCPs and
Key Achievements:
Successfully built launch and growth phase strategy changing conventional wisdom; Nplate first year
sales doubled external forecasts and 3-year CAGR beat industry average for launch products by 240%
Brad S. Pruitt Page Two

Led global commercial plan development in collaboration with U.S. and regional affiliate marketing,
market research, health economics, PR, corporate communications and advocacy functions
Led global payer landscape assessment and development of global payer plan in collaboration with
health economics, managed markets and regional affiliates
Worked effectively in matrix environment across medical affairs, regulatory, R&D, finance, legal, CMC,
global operations and distribution functions

Eli Lilly and Company, Indianapolis, Indiana 1989 2004

Senior Manager of Marketing Neuroscience 1999 2004

Launch leader for cornerstone of corporate strategy
Promoted to lead pre-market strategic planning and launch readiness for Strattera

. Successful launch was

cornerstone to Lillys corporate strategy to offset 32% revenue loss due to Prozac

patent expiration. High

visibility role with frequent presentations to senior management and launch challenge teams.
Key Achievements:
Strategic commercial plan created a uniquely positioned brand that contributed to $376M in first-year
and $710M in third-year net revenues
Extended reach to 75% of undiagnosed patients and conceived and led collaborative development of
short-form screener with KOLs in association with the World Health Organization
Recipient of Launch MVP and Marketing Excellence Innovation with ROI awards
Recognized among top 2% of marketing leadership with Presidents Council honor


Bachelor of Pharmacy, Washington State University Pullman, Washington
Board Certified Registered Pharmacist

Reasoning, Data Analysis & Writing Certification Duke University
Model Thinking for Strategic Planning & Decision-Making Certification University of Michigan
Six Sigma Black Belt Certification
SCRUM Master, Agile Development


Board of Directors, Sarcoma Foundation of America 2013 Present
Committee member providing commercial and marketing guidance for Vision 2020, a biopharmaceutical
business development partnership. Vision 2020 is a tumor tissue derived genomics database of molecular
targets/pathways offering greater efficiency and accelerating target-to-drug match for industry.

Brad S. Pruitt Page Three